Gemlipid en es it fr

Gemlipid Brand names, Gemlipid Analogs

Gemlipid Brand Names Mixture

  • No information avaliable

Gemlipid Chemical_Formula


Gemlipid RX_link

Gemlipid fda sheet

Gemlipid FDA

Gemlipid msds (material safety sheet)

Gemlipid Synthesis Reference

P. L. CREGER, U.S. Pat. 3,674,836 (1972)

Gemlipid Molecular Weight

250.333 g/mol

Gemlipid Melting Point

61-63 oC

Gemlipid H2O Solubility

10 mg/mL (in base)

Gemlipid State


Gemlipid LogP


Gemlipid Dosage Forms

Tablets; Capsules

Gemlipid Indication

For treatment of adult patients with very high elevations of serum triglyceride levels (types IV and V hyperlipidemia) who are at risk of developing pancreatitis (inflammation of the pancreas) and who do not respond adequately to a strict diet.

Gemlipid Pharmacology

Gemfibrozil, a fibric acid antilipemic agent similar to clofibrate, is used to treat hyperlipoproteinemia and as a second-line therapy for type IIb hypercholesterolemia. It acts to reduce triglyceride levels, reduce VLDL levels, reduce LDL levels (moderately), and increase HDL levels (moderately).

Gemlipid Absorption

Well absorbed from gastrointestinal tract (within 1-2 hours).

Gemlipid side effects and Toxicity

Oral, mouse: LD50 = 3162 mg/kg. Symptoms of overdose include abdominal cramps, diarrhea, joint and muscle pain, nausea, and vomiting.

Gemlipid Patient Information

Gemfibrozil is used to lower high triglyceride and cholesterol levels. Notify your physician if you are pregnant or nursing. Gemfibrozil should be taken 30 minutes before the morning and evening meals. This medication may cause dizziness or blurred vision; use caution while driving or operating hazardous machinery. Gemfibrozil may cause an increase in blood sugar. If you have diabetes mellitus, carefully monitor blood sugar levels. Notify your physician if you develop severe stomach pain, muscle pain or weakness, or unexplained fever.

Gemlipid Organisms Affected

Humans and other mammals